In sum, the results indicate that the combination of IM + anti-VEGF is immunostimulatory and that both CD8 and CD4 T cells are cooperatively contributing to therapeutically effective immune responses in mouse models of GBM. The gene discussed is VEGFA; the disease is glioblastoma.